144 ·Filed Apr 15, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
Monitor for actual Form 4 or subsequent 144 filings to confirm if the sale proceeds; routine for directors, but worth tracking in context of broader insider activity.
Final — all horizons settled through T+60d
MIRM ▲ +24.18% at T+60d
NEUTRAL call ✓ call won +24.18% · α vs SPY +17.13% · entry $95.86 → $119.04
T+1d
+2.18%
call +2.18% · α +0.97%
$97.95
settled 6mo ago
T+5d
-4.08%
call -4.08% · α -5.06%
$91.95
settled 5mo ago
T+20d
+13.87%
call +13.87% · α +8.06%
$109.16
settled 5mo ago
T+60d
+24.18%
call +24.18% · α +17.13%
$119.04
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Saira Ramasastry, a director at Mirum Pharmaceuticals, filed a Form 144 to notify the sale of 2,000 shares of common stock, valued at approximately $193,800, following a stock option exercise. The shares are intended for sale on or after April 15, 2026.
Key Facts
- Saira Ramasastry is a director at Mirum Pharmaceuticals.
- Filed Form 144 for the proposed sale of 2,000 shares of common stock.
- Shares to be sold following a stock option exercise on April 15, 2026.
- Approximate sale value: $193,800 (based on $96.90/share).
- No immediate sale has occurred; this is a notice of intent to sell.
Financial Impact
Approximately $193,800 in potential proceeds from the sale of 2,000 shares.
insider ownershipshare float
Risk Factors
- Perception of insider selling ahead of key catalysts could pressure sentiment, though this is a routine transaction.
- Minimal financial impact given small volume relative to company's $5.8B market cap.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003474 |
| Document: 0001950047-26-003474-index.html | 0001950047-26-003474 |
| Document: 0001950047-26-003474.txt | 0001950047-26-003474 |
16 reports for MIRM
80% Hit rate best @ T+20▲ +28.29%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Insider Cluster | $102.24 $98.82 | ▼ −3.35% | ▼ −1.39% | $82.93 (−18.89%) |
Aug 12, 2026 7w ago | Insider Cluster | $98.97 $100.61 | ▲ +1.66% | ▲ +3.55% | $82.93 (−16.21%) |
Aug 11, 2026 7w ago | Insider Cluster | $98.97 $100.61 | ▼ −1.66% | ▼ −3.55% | $82.93 (+16.21%) |
Aug 10, 2026 7w ago | 144 | $98.23 $98.30 | ▲ +0.07% | ▲ +1.13% | $82.93 (−15.58%) |
Aug 5, 2026 8w ago | 8-K | $94.12 $100.63 | ▲ +6.92% | ▲ +6.32% | $82.93 (−11.88%) |
Jul 8, 2026 12w ago | Insider Cluster | $128.57 $105.79 | ▼ −17.72% | ▼ −20.99% | $82.93 (−35.50%) |
Jun 11, 2026 16w ago | Institutional Cluster | $99.54 $127.70 | ▲ +28.29% | ▲ +26.40% | $82.93 (−16.69%) |
Jun 10, 2026 16w ago | Insider Cluster | $94.00 $127.70 | ▲ +35.85% | ▲ +32.23% | $82.93 (−11.78%) |
Jun 2, 2026 17w ago | Insider Cluster | $91.84 $125.59 | ▲ +36.76% | ▲ +37.76% | $82.93 (−9.70%) |
Jun 1, 2026 17w ago | 144 | $92.17 $120.46 | ▲ +30.69% | ▲ +32.26% | $82.93 (−10.02%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Mon (65h 29m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access